Vitamin D status in pregnancy and the effects of vitamin D supplementation in ethnic minority groups - Vitamin D in pregnancy

Status

Not yet recruiting

Phases

Unknown

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2006-006080-23-GB

Enrollment

135

Registered

2006-12-07

Start date

2007-03-21

Completion date

Unknown

Last updated

2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low vitamin D levels in pregnant women especially in ethnic minority groups

Interventions

Product Name: Ergocalciferol tablets Product Code: vitamin d Pharmaceutical Form: Coated tablet INN or Proposed INN: calciferol tablets Other descriptive name: VITAMIN D Concentration unit: IU interna

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Pregnant women from ethnic minority populations (45 Afro-Caribbean, 45 Middle East or Far East or Indian subcontinent) and 45 Caucasians as controls Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Unable to speak English to give consent

Design outcomes

Primary

Measure	Time frame
Main Objective: Main objective: To compare the Vitamin D status of pregnant women from ethnic minorities versus Caucasians in North West Thames, London and to evaluate the effects of daily and of single-dose vitamin D supplementation in pregnant women and their babies in the last trimester;Secondary Objective: ;Primary end point(s): Main outcome measures: Cord blood calcium and vitamin D levels in the neonate; Secondary outcome measures: Maternal and cord parathyroid hormone and calcium levels at delivery	—

Measure

Time frame

Main Objective: Main objective: To compare the Vitamin D status of pregnant women from ethnic minorities versus Caucasians in North West Thames, London and to evaluate the effects of daily and of single-dose vitamin D supplementation in pregnant women and their babies in the last trimester;Secondary Objective: ;Primary end point(s): Main outcome measures: Cord blood calcium and vitamin D levels in the neonate; Secondary outcome measures: Maternal and cord parathyroid hormone and calcium levels at delivery

—

Countries

United Kingdom

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026